Corona Remedies IPO GMP Today
The Corona Remedies IPO GMP is ₹342 (+32.2% over the upper price band of ₹1,062) as of 15 Dec 2025, giving an estimated listing price of ₹1,404 per share. On a minimum application of 14 shares, that is an estimated gain of ₹4,788. GMP has risen by ₹35 since tracking began on 3 Dec.
Last updated
- Issue Price
- ₹1,062
- GMP
- ₹342
- GMP %
- +32.2%
- Est. listing
- ₹1,404
- Est. gain / application
- +₹4,788
Corona Remedies IPO GMP trend
Tracked for 14 days. High ₹365 on 4 Dec, low ₹0 on 2 Dec.
Corona Remedies IPO GMP day-wise
| Date | GMP | Change | GMP % | Est. listing | Est. gain (14 sh) |
|---|---|---|---|---|---|
| (latest) | ₹342 | 0 | 32.20% | ₹1,404 | +₹4,788 |
| ₹342 | +₹47 | 32.20% | ₹1,404 | +₹4,788 | |
| ₹295 | -₹35 | 27.78% | ₹1,357 | +₹4,130 | |
| ₹330 | +₹39 | 31.07% | ₹1,392 | +₹4,620 | |
| ₹291 | -₹4 | 27.40% | ₹1,353 | +₹4,074 | |
| ₹295 | +₹25 | 27.78% | ₹1,357 | +₹4,130 | |
| ₹270 | +₹8 | 25.42% | ₹1,332 | +₹3,780 | |
| ₹262 | -₹28 | 24.67% | ₹1,324 | +₹3,668 | |
| ₹290 | -₹15 | 27.31% | ₹1,352 | +₹4,060 | |
| ₹305 | -₹60 | 28.72% | ₹1,367 | +₹4,270 | |
| ₹365 | 0 | 34.37% | ₹1,427 | +₹5,110 | |
| ₹365 | +₹365 | 34.37% | ₹1,427 | +₹5,110 | |
| ₹0 | -₹307 | 0.00% | ₹1,062 | ₹0 | |
| ₹307 | — | 28.91% | ₹1,369 | +₹4,298 |
Est. listing = upper price band (₹1,062) + GMP. Est. gain = GMP × 14 shares (1 lot, the minimum application).
Corona Remedies IPO subscription status
| QIB | 278.52x |
|---|---|
| bNII | 234.02x |
| sNII | 158.62x |
| Retail | 28.73x |
| Total | 137.04x |
Reading the Corona Remedies IPO GMP
The grey market premium is the price above the issue price at which Corona Remedies IPO shares are informally traded before listing. A GMP of ₹342 on an upper band of ₹1,062 suggests the shares could open around ₹1,404, if grey market sentiment holds until listing day.
GMP is not set by the company, the exchanges or SEBI. It moves daily with market conditions and subscription demand. Check it together with the subscription numbers and the company's financials before applying.
Corona Remedies IPO GMP: FAQs
- What is Corona Remedies IPO GMP today?
- The latest grey market premium (GMP) for the Corona Remedies IPO is ₹342 as of 15 December 2025, which is 32.20% over the upper price band of ₹1,062.
- What is the expected listing price of Corona Remedies IPO?
- Based on the current GMP, the estimated listing price of Corona Remedies IPO is ₹1,404 per share (₹1,062 issue price + ₹342 GMP). This is an estimate from unofficial grey market trades, not a guaranteed listing price.
- What is the lot size and minimum investment for Corona Remedies IPO?
- The lot size is 14 shares. The minimum application is 1 lot, which costs ₹14,868 at the upper price band.
- Is IPO GMP reliable?
- GMP reflects unofficial trades before listing and changes daily with market mood and subscription demand. It is a useful sentiment indicator but often differs from the actual listing price, so use it alongside the company's financials and subscription data.
GMP is an unofficial indicator compiled from grey market sources and is not investment advice. Actual listing prices can differ significantly. Read the offer document before investing.